HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: P&G

This article was originally published in The Rose Sheet

Executive Summary

P&G: North American unit volume up 2% in the third quarter of FY 1997 (ended March 31), while sales "remained stable" due to lower pricing in the laundry category, Procter & Gamble said April 24. Net earnings for the three months advanced 6% "as the region continued to benefit from cost savings generated from simplification and standardization efforts," the company noted. Consolidated P&G sales climbed 2.1% to $8.8 bil., while net earnings jumped 15.9% to $881 mil...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004082

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel